MedTrace Logo

Indocyanine Green Lymphography in Management of Lingual Lymphatic Malformation

NCT06755905 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2025-03-13

No results posted yet for this study

Summary

To elucidate the application of indocyanine green (ICG) fluorescence angiography in the treatment of childhood tongue cLM (clinically localized malignancy, presumed context here), providing a clearer scientific basis for subsequent targeted interventions.

Conditions

  • Lymphatic Malformation

Interventions

PROCEDURE

ICGL-guided treatment

Indocyanine green lymphography guided resection combined with sclerotherapy

PROCEDURE

Conventional Treatment group

Resection with sclerotherapy

Sponsors & Collaborators

  • Nanjing Children's Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2024-06-30
Completion
2024-12-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06755905 on ClinicalTrials.gov